PMC:7160442 / 6365-7280
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 87 | 687-697 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 88 | 699-717 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 89 | 739-748 | Chemical | denotes | lopinavir | MESH:D061466 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T3 | 182-187 | Body_part | denotes | scale | http://purl.obolibrary.org/obo/UBERON_0002542 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T30 | 86-100 | Disease | denotes | infectiousness | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T33 | 4-9 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focus |
| T34 | 67-72 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T35 | 129-134 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
| T36 | 499-500 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T37 | 556-568 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
| T38 | 722-723 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T39 | 807-808 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T40 | 905-907 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 512-521 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T2 | 532-537 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T3 | 687-697 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T4 | 699-717 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T5 | 739-762 | Chemical | denotes | lopinavir and ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T6 | 739-748 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T7 | 753-762 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T8 | 779-789 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T9 | 790-794 | Chemical | denotes | beta | http://purl.obolibrary.org/obo/CHEBI_10545 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T38 | 0-101 | Sentence | denotes | The focus of ongoing research includes determining the duration of virus shedding and infectiousness. |
| T39 | 102-235 | Sentence | denotes | Development of serological tests with good sensitivity and specificity for wide-scale use is necessary to assess population immunity. |
| T40 | 236-414 | Sentence | denotes | Serological studies have been started in several European countries to define population immunity and studies on the duration of immunity will need to be conducted in the future. |
| T41 | 415-538 | Sentence | denotes | Clinical trials are being conducted worldwide to investigate treatment options with a variety of antiviral and other drugs. |
| T42 | 539-806 | Sentence | denotes | The World Health Organization (WHO) and European Union-funded projects are coordinating multi-centre adaptive trials to assess the effectiveness of remdesivir, hydroxychloroquine and a combination of lopinavir and ritonavir with or without interferon-beta-1a [16,17]. |
| T43 | 807-915 | Sentence | denotes | A number of vaccine trials are ongoing worldwide with earliest results expected within the coming 18 months. |